Squarepoint Ops LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$27,410
-90.7%
27,969
-84.9%
0.00%
-100.0%
Q1 2023$294,056
-64.1%
184,941
+40.6%
0.00%
-66.7%
Q4 2022$819,469
+111.2%
131,536
+127.3%
0.00%
+50.0%
Q3 2022$388,000
+26.8%
57,862
+20.4%
0.00%0.0%
Q2 2022$306,000
-15.5%
48,065
-33.6%
0.00%
+100.0%
Q4 2021$362,000
-58.6%
72,352
-0.2%
0.00%
-66.7%
Q3 2021$874,000
+5.3%
72,499
+84.8%
0.00%0.0%
Q2 2021$830,000
+51.5%
39,236
+100.7%
0.00%0.0%
Q1 2021$548,000
+39.4%
19,545
+29.4%
0.00%0.0%
Q4 2020$393,000
-76.0%
15,109
-45.0%
0.00%
-70.0%
Q4 2019$1,639,000
+51.6%
27,480
-6.8%
0.01%0.0%
Q3 2019$1,081,000
+13.9%
29,492
+44.6%
0.01%
+11.1%
Q2 2019$949,000
-34.4%
20,400
-43.4%
0.01%
-40.0%
Q1 2019$1,447,000
+83.2%
36,043
+109.8%
0.02%
+66.7%
Q4 2018$790,000
-38.2%
17,182
-40.4%
0.01%
-40.0%
Q3 2018$1,278,000
-23.7%
28,808
-32.6%
0.02%
-31.8%
Q2 2018$1,675,000
+22.6%
42,748
+126.3%
0.02%0.0%
Q1 2018$1,366,000
+100.9%
18,886
+82.9%
0.02%
+83.3%
Q4 2017$680,000
+146.4%
10,325
+31.9%
0.01%
+50.0%
Q1 2017$276,000
+109.1%
7,826
-26.0%
0.01%
+60.0%
Q4 2016$132,000
-81.2%
10,577
-74.6%
0.01%
-90.7%
Q1 2016$703,000
+71.9%
41,600
+732.0%
0.05%
-59.4%
Q2 2015$409,0005,0000.13%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$69,675,00019.39%
Endurant Capital Management LP 207,293$5,390,0001.94%
Bellevue Group AG 5,138,451$133,599,0001.53%
Rhenman & Partners Asset Management AB 592,225$15,398,0001.26%
PLATINUM INVESTMENT MANAGEMENT LTD 1,562,869$40,635,0000.93%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 31,434$817,0000.62%
WASATCH ADVISORS LP 3,998,010$103,949,0000.51%
HAMILTON LANE ADVISORS LLC 46,181$1,201,0000.45%
Boxer Capital, LLC 500,000$13,000,0000.42%
DCF Advisers, LLC 38,500$1,001,0000.41%
View complete list of ESPERION THERAPEUTICS INC NE shareholders